Literature DB >> 14672402

Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes.

Vincent van Iterson1, Marjut Leidenius, Leena Krogerus, Karl von Smitten.   

Abstract

In patients with tumor positive sentinel nodes, axillary lymph node dissection is routinely performed while a majority of these patients have no tumor involvement in the non-sentinel nodes. The authors tried to identify a subgroup of patients with a tumor positive sentinel node without non-sentinel node tumor involvement. In 135 consecutive patients with tumor positive sentinel nodes and axillary lymph node dissection performed, the incidence of non-sentinel node involvement according to tumor and sentinel node related factors was examined. The size of the sentinel node metastasis, size of primary tumor and number of tumor positive sentinel nodes were the three factors significantly predicting the status of the non-sentinel nodes. The size of the sentinel node metastasis was the strongest predictive factor (P < 0.0001). In a subgroup of 41 patients with a stage T1 tumor and micrometastatic involvement in the sentinel node only 2 patients (5%) had non-sentinel node involvement. In patients with small primary tumors and micrometastatic involvement of the sentinel nodes, the chance of non-sentinel node involvement is small but cannot be discarded. Because the clinical relevance of micrometastases in lymph nodes is still unclear it is not advisable to omit axillary lymph node dissection even in these patients.

Entities:  

Mesh:

Year:  2003        PMID: 14672402     DOI: 10.1023/B:BREA.0000003918.59396.e4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  4 in total

Review 1.  Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.

Authors:  Carolien H M van Deurzen; Maaike de Boer; Evelyn M Monninkhof; Peter Bult; Elsken van der Wall; Vivianne C G Tjan-Heijnen; Paul J van Diest
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

2.  Lymphangiogenesis and lymphatic metastasis in breast cancer.

Authors:  Sophia Ran; Lisa Volk; Kelly Hall; Michael J Flister
Journal:  Pathophysiology       Date:  2009-12-24

3.  Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.

Authors:  Hélène Bonsang-Kitzis; Delphine Mouttet-Boizat; Eugénie Guillot; Jean-Guillaume Feron; Virginie Fourchotte; Séverine Alran; Jean-Yves Pierga; Paul Cottu; Florence Lerebours; Denise Stevens; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; François Campana; Roman Rouzier; Fabien Reyal
Journal:  PLoS One       Date:  2017-02-27       Impact factor: 3.240

4.  Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.

Authors:  Y Ohi; Y Umekita; Y Sagara; Y Rai; D Yotsumoto; A Matsukata; S Baba; S Tamada; Y Matsuyama; M Ando; Y Sagara; M Sasaki; S Tsuchimochi; A Tanimoto; Y Sagara
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.